- Home
- EXOZ vs JSPR Comparison
EXOZ vs JSPR Comparison
Compare EXOZ & JSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EXOZ
- JSPR
- Stock Information
- Founded
- EXOZ 2014
- JSPR 2018
- Country
- EXOZ United States
- JSPR United States
- Employees
- EXOZ N/A
- JSPR N/A
- Industry
- EXOZ
- JSPR Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- EXOZ
- JSPR Health Care
- Exchange
- EXOZ NYSE
- JSPR Nasdaq
- Market Cap
- EXOZ 89.8M
- JSPR 85.8M
- IPO Year
- EXOZ N/A
- JSPR N/A
- Fundamental
- Price
- EXOZ $13.70
- JSPR $5.70
- Analyst Decision
- EXOZ
- JSPR Strong Buy
- Analyst Count
- EXOZ 0
- JSPR 11
- Target Price
- EXOZ N/A
- JSPR $62.22
- AVG Volume (30 Days)
- EXOZ 14.8K
- JSPR 204.2K
- Earning Date
- EXOZ 06-13-2025
- JSPR 05-12-2025
- Dividend Yield
- EXOZ N/A
- JSPR N/A
- EPS Growth
- EXOZ N/A
- JSPR N/A
- EPS
- EXOZ N/A
- JSPR N/A
- Revenue
- EXOZ N/A
- JSPR N/A
- Revenue This Year
- EXOZ N/A
- JSPR N/A
- Revenue Next Year
- EXOZ N/A
- JSPR N/A
- P/E Ratio
- EXOZ N/A
- JSPR N/A
- Revenue Growth
- EXOZ N/A
- JSPR N/A
- 52 Week Low
- EXOZ $8.50
- JSPR $3.13
- 52 Week High
- EXOZ $23.99
- JSPR $26.84
- Technical
- Relative Strength Index (RSI)
- EXOZ N/A
- JSPR 61.07
- Support Level
- EXOZ N/A
- JSPR $4.57
- Resistance Level
- EXOZ N/A
- JSPR $6.20
- Average True Range (ATR)
- EXOZ 0.00
- JSPR 0.42
- MACD
- EXOZ 0.00
- JSPR 0.10
- Stochastic Oscillator
- EXOZ 0.00
- JSPR 69.33
About EXOZ EXOZYMES INC
EXoZymes Inc is focused on using a biomanufacturing platform to create valuable biochemicals, including Active Pharmaceutical Ingredients or APIs, biofuels, food flavors, and cosmetics, offering a sustainable alternative to traditional chemical production methods.
About JSPR Jasper Therapeutics Inc.
Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy.